Definitive Contract 75A50119C00013
Award Date
2/12/19
Potential Completion Date
1/31/22
Potential Value
$9.3M
Awardee
Vaccitech (Uk) LIMITED
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...
This federal contract award was issued by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corp, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $357,198.29 Firm Fixed Price delivery order supports Protein Sciences' research, development, manufacturing, and testing of vaccine candidates, antigens,...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $63,239,785.00 definitive contract to Arcturus Therapeutics, Inc. for the procurement of a pandemic influenza vaccine (PandFlu) and a quadrivalent seasonal influenza vaccine (QsFlu). This contract is not a set-aside and supports the Arcturus self-amplifying mRNA-based vaccine platform for rapid pandemic influenza response, a key priority under ASPR's Biomedical...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Vaxine PTY LTD, a for-profit organization located in Australia. The $18,541,473.00 contract is for the "ADVANCED DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES". The contract has an end date of August 14, 2023 and was initially awarded on September 20, 2018. This contract...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
This is a $228,598,975.00 definitive cost-sharing contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janssen Research & Development, LLC. The contract was issued under ASPR's Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) focused on the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and...
This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Public Health England, a vendor located in Great Britain, United Kingdom. The contract has a potential value of $3,468,232.00 and was awarded on February 26, 2018 as a Delivery Order under the Biological Animal Model Development 2017-2022 Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract is a Cost Plus Fixed Fee type...
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority awarded a $269,952,453 firm fixed price definitive contract to Global Health Investment Corporation, a nonprofit organization. This contract establishes a public-private partnership through BARDA's other transaction authority to address gaps in pandemic preparedness and response. Specifically, the partnership will foster and accelerate medical countermeasure development using strategic venture...
This is a $5,570,766.33 delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to the UK Health Security Agency, formerly known as Public Health England. The contract is for biological animal model and medical countermeasure development services to support the Biomedical Advanced Research and Development Authority's (BARDA) efforts to combat chemical, biological, radiological, and nuclear threats....
This is a delivery order awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corporation, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The $1,986,163.00 fixed-price order funds Protein Sciences to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support...